Lisa Cronin

Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source　- Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.

H. Diener, S. Uchiyama, K. Toyoda, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

R. Sacco, H. Diener, J. Ferro, 2019, The New England journal of medicine.

Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents

T. Lehr, L. Mitchell, S. Haertter, 2016, Thrombosis and Haemostasis.

Stroke in Relation to Cardiac Procedures in Patients With Non–ST-Elevation Acute Coronary Syndrome: A Study Involving >18 000 Patients

S. Yusuf, J. Pogue, A. Budaj, 2001, Circulation.

Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial

R. Wachter, R. Sacco, M. Brainin, 2021, Circulation.

Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS Trial

R. Sacco, C. Granger, C. Molina, 2022, Journal of the American Heart Association.

Design of Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate vs. Acetylsalicylic Acid in Patients with Embolic Stroke of Undetermined Source (Re-Spect Esus)

R. Sacco, H. Diener, C. Granger, 2015, International journal of stroke : official journal of the International Stroke Society.

Antithrombotic Treatment of Embolic Stroke of Undetermined Source RE-SPECT ESUS Elderly and Renally Impaired Subgroups

R. Sacco, H. Diener, M. Brainin, 2020, Stroke.

286Predictors of atrial fibrillation in patients with embolic stroke of undetermined source: an analysis of the RE-SPECT ESUS trial

R. Sacco, C. Granger, M. Bahit, 2019, European Heart Journal.